Dr. Datsons shines on inking MoU with AL-Mugdh Pharma

03 Mar 2015 Evaluate

Dr. Datasons Labs is currently trading at Rs. 7.94, up by 0.30 points or 3.93% from its previous closing of Rs. 7.64 on the BSE.

The scrip opened at Rs. 7.89 and has touched a high and low of Rs. 8.46 and Rs. 7.51 respectively. So far 1714829 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 70.80 on 10-Mar-2014 and a 52 week low of Rs. 6.03 on 25-Feb-2015.

Last one week high and low of the scrip stood at Rs. 8.46 and Rs. 6.03 respectively. The current market cap of the company is Rs. 87.12 crore.

The institutions and non-institutions held 38.87% and 61.13% stake in the company, respectively.

Dr. Datsons Labs and AL-Mugdh Pharma of Yemen have signed a licensing, distribution and supply deal, under which the distribution company will market Anti-Malarial Drugs. The company is also looking to widen its product basket to cater to the regulated & semi regulated market.

Dr. Datsons Labs is a leading research based integrated pharmaceutical company with established research, manufacturing and marketing capabilities. It is R&D focused, has a multi product portfolio with state of the art manufacturing facilities, and is set to become a marketing conglomerate across the globe.

 

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×